AI-generated summary
This is a protocol for a planned randomized, double-blind trial in women within 12 hours of vaginal delivery with perineal trauma or vulvar edema and pain. The authors plan to compare a single 808-nm laser photobiomodulation session with a sham intervention, but no results are reported. The abstract notes that the study is a protocol and that its expected benefits are hypotheses.
- Who or what was studied
- Women aged over 15 years within 12 hours after vaginal delivery, with first- or second-degree perineal trauma and/or vulvar edema and pain of at least 3 on the Numeric Rating Scale
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract describes a trial protocol only, so no outcomes have been measured and the expected effects are unproven.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Objective
To evaluate the efficacy of photobiomodulation (PBM) in reducing perineal pain and obstetric vulvar edema, as well os its effects on maternal functioning during the immediate postpartum period.
Methods
This randomized, controlled, double-blind clinical trial protocol will include women aged over 15 years, within 12 h after vaginal delivery, presenting with first- or second-degree perineal trauma and/or vulvar edema and pain ≥ 3 on the Numeric Rating Scale. Participants will be randomized in blocks of four to receive PBM or a sham intervention alongside usual postpartum care. A single PBM session will be performed using 808-nm infrared laser light at an output power of 100 mW. Assessments will be performed at baseline, immediately after the intervention, 12 h, 40 days, and three months postpartum. Outcomes will include pain, pressure pain threshold, vulvar edema area, maternal functioning, treatment satisfaction, urinary incontinence, and sexual function. Statistical analysis will follow the intention-to-treat principle using linear mixed-effects models, with group, time, and group × time interaction as fixed effects and participant as a random effect. Post-hoc comparisons will use Bonferroni correction, with a significance level of 5%.
Conclusion
PBM is expected to reduce perineal pain and vulvar edema and improve maternal functioning. The randomized design, sham control, blinded outcome assessment, and longitudinal analysis are expected to provide evidence regarding the efficacy and safety of PBM as a non-pharmacological strategy for postpartum care.
Trial Registration
Brazilian Clinical Trials Registry (REBEC), RBR9sgdsm2, approved on July 7, 2026.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 100 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Sham, Trial registration, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.